January 27, 2015 8:54 AM ET


Company Overview of Tempero Pharmaceuticals, Inc.

Company Overview

Tempero Pharmaceuticals, Inc. develops medicines for the treatment of autoimmune diseases. It develops therapies that selectively prevent Th17-driven diseases, or enhance the development of specialized Treg subsets. Its products treat autoimmune disorders, such as multiple sclerosis, inflammatory bowel disease, psoriasis, and type 1 diabetes. The company was founded in 2009 and is based in Cambridge, Massachusetts.

200 Technology Square

Suite 602

Cambridge, MA 02139

United States

Founded in 2009



Key Executives for Tempero Pharmaceuticals, Inc.

Chief Executive Officer and President
Age: 53
Founder and Member of Scientific Advisory Board
Founder and Member of Scientific Advisory Board
Founder and Member of Scientific Advisory Board
Senior Director of Drug Discovery
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
BioIncept LLC United States
Proneuron Biotechnologies, Inc. United States
Cardinal Health 404, Inc. United States
Takeda Vaccines (Montana), Inc. United States
Spectra Stable Isotopes United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tempero Pharmaceuticals, Inc., please visit www.temperopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.